HK1139076A1 - Lyophilized preparation comprising influenza vaccine, and method for preparation thereof - Google Patents

Lyophilized preparation comprising influenza vaccine, and method for preparation thereof

Info

Publication number
HK1139076A1
HK1139076A1 HK10105830.1A HK10105830A HK1139076A1 HK 1139076 A1 HK1139076 A1 HK 1139076A1 HK 10105830 A HK10105830 A HK 10105830A HK 1139076 A1 HK1139076 A1 HK 1139076A1
Authority
HK
Hong Kong
Prior art keywords
influenza vaccine
preparation
freeze
iii
dried preparation
Prior art date
Application number
HK10105830.1A
Other languages
English (en)
Inventor
Chikamasa Yamashita
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of HK1139076A1 publication Critical patent/HK1139076A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16051—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Wood Science & Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HK10105830.1A 2007-03-09 2010-06-10 Lyophilized preparation comprising influenza vaccine, and method for preparation thereof HK1139076A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007059724 2007-03-09
PCT/JP2008/054210 WO2008111532A1 (ja) 2007-03-09 2008-03-07 インフルエンザワクチン含有凍結乾燥製剤、及びその製造方法

Publications (1)

Publication Number Publication Date
HK1139076A1 true HK1139076A1 (en) 2010-09-10

Family

ID=39759470

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10105830.1A HK1139076A1 (en) 2007-03-09 2010-06-10 Lyophilized preparation comprising influenza vaccine, and method for preparation thereof

Country Status (20)

Country Link
US (1) US8216588B2 (zh)
EP (1) EP2119451A4 (zh)
JP (1) JP5388842B2 (zh)
KR (1) KR20090128463A (zh)
CN (1) CN101631563B (zh)
AR (1) AR065640A1 (zh)
AU (1) AU2008225501B2 (zh)
BR (1) BRPI0808037A2 (zh)
CA (1) CA2680193C (zh)
HK (1) HK1139076A1 (zh)
IL (1) IL200588A0 (zh)
MX (1) MX2009009635A (zh)
MY (1) MY149924A (zh)
NZ (1) NZ579395A (zh)
RU (1) RU2484847C2 (zh)
SG (1) SG179406A1 (zh)
TW (1) TWI428140B (zh)
UA (1) UA97391C2 (zh)
WO (1) WO2008111532A1 (zh)
ZA (1) ZA200905952B (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0614460D0 (en) * 2006-07-20 2006-08-30 Novartis Ag Vaccines
CN108588035A (zh) * 2011-06-28 2018-09-28 白血球保健股份有限公司 病毒或细菌的新型稳定方法
ES2659066T3 (es) * 2013-01-25 2018-03-13 Wintermute Biomedical, Inc. Compuestos terapéuticos
GB201314248D0 (en) * 2013-08-08 2013-09-25 Glaxosmithkline Biolog Sa Saccharide vaccine formulation
CA2923010C (en) 2013-09-03 2022-08-30 Georgia Tech Research Corporation Thermally stable vaccine formulations and microneedles
EP3060247A1 (en) * 2013-10-25 2016-08-31 Leukocare Ag A novel method for the production of stabile vaccines
TW201722478A (zh) * 2015-11-27 2017-07-01 Nitto Denko Corp 流感疫苗乾燥製劑、及流感疫苗乾燥製劑之製造方法
WO2017090766A1 (ja) 2015-11-27 2017-06-01 日東電工株式会社 口腔内投与用ワクチン医薬組成物及び口腔内投与用ワクチン医薬組成物の製造方法
EP3381468A4 (en) * 2015-11-27 2019-06-05 Nitto Denko Corporation DRIED INFLUENZA VACCINE PREPARATION AND METHOD FOR PRODUCING A DRIED INFLUENZED VACCINE PREPARATION
AU2018217906A1 (en) 2017-02-13 2019-08-15 Wintermute Biomedical, Inc. Anti-pathogenic therapeutic compositions
KR20210108942A (ko) 2018-10-01 2021-09-03 윈터뮤트 바이오메디컬 인코포레이티드 치료 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2505657A1 (fr) 1981-05-13 1982-11-19 Pasteur Institut Perfectionnements apportes aux agents de stabilisation de virus vivants pour la preparation de vaccins, et vaccins stabilises contenant lesdits agents de stabilisation
US4537769A (en) 1982-04-06 1985-08-27 American Cyanamid Company Stabilization of influenza virus vaccine
JPH07121871B2 (ja) * 1986-10-09 1995-12-25 国立予防衛生研究所長 インフルエンザワクチン凍結乾燥製剤
JPH05229960A (ja) * 1990-10-30 1993-09-07 Dai Ichi Seiyaku Co Ltd 新規インフルエンザワクチン
JPH0813753B2 (ja) * 1992-05-22 1996-02-14 株式会社微生物化学研究所 牛伝染性鼻気管炎ウイルス感染症、牛ウイルス性下痢−粘膜病ウイルス感染症、パラインフルエンザ３型ウイルス感染症、牛ｒｓウイルス感染症および牛アデノ７型ウイルス感染症５種混合生ワクチン
MXPA02009485A (es) 2000-03-31 2003-03-10 Kirin Brewery Preparacion en polvo para administracion a traves de la mucosa, que comprende un farmaco de alto peso molecular y que muestra una estabilidad mejorada en almacenamiento.
EG24184A (en) * 2001-06-15 2008-10-08 Otsuka Pharma Co Ltd Dry powder inhalation system for transpulmonary
JP2004054555A (ja) * 2002-07-19 2004-02-19 Yokogawa Electric Corp 表示装置
KR101190932B1 (ko) * 2003-02-25 2012-10-16 메디뮨 엘엘씨 인플루엔자 백신 조성물의 제조 방법
ES2633471T3 (es) * 2004-10-06 2017-09-21 Medimmune, Llc Composiciones de vacuna contra la gripe estables a temperatura de refrigerador
RU2290205C1 (ru) * 2005-09-13 2006-12-27 Федеральное государственное унитарное предприятие "Научно-производственное объединение по медицинским иммунологическим препаратам "МИКРОГЕН" Министерства здравоохранения Российской Федерации Способ получения живой вакцины для профилактики гриппа

Also Published As

Publication number Publication date
US20100104595A1 (en) 2010-04-29
UA97391C2 (ru) 2012-02-10
MY149924A (en) 2013-10-31
CN101631563A (zh) 2010-01-20
EP2119451A4 (en) 2012-05-16
EP2119451A1 (en) 2009-11-18
IL200588A0 (en) 2010-05-17
RU2484847C2 (ru) 2013-06-20
AR065640A1 (es) 2009-06-17
SG179406A1 (en) 2012-04-27
AU2008225501B2 (en) 2013-08-29
JP5388842B2 (ja) 2014-01-15
TWI428140B (zh) 2014-03-01
KR20090128463A (ko) 2009-12-15
MX2009009635A (es) 2009-09-22
CA2680193C (en) 2015-05-05
WO2008111532A1 (ja) 2008-09-18
TW200848074A (en) 2008-12-16
AU2008225501A1 (en) 2008-09-18
ZA200905952B (en) 2010-11-24
CA2680193A1 (en) 2008-09-18
RU2009137380A (ru) 2011-04-20
AU2008225501A2 (en) 2009-09-24
JPWO2008111532A1 (ja) 2010-06-24
CN101631563B (zh) 2013-07-24
US8216588B2 (en) 2012-07-10
BRPI0808037A2 (pt) 2014-06-17
NZ579395A (en) 2012-05-25

Similar Documents

Publication Publication Date Title
HK1139076A1 (en) Lyophilized preparation comprising influenza vaccine, and method for preparation thereof
WO2010149743A3 (en) Vaccine
WO2007035455A3 (en) Stabilizers for freeze-dried vaccines
EP4349405A3 (en) Respiratory virus vaccines
MX358836B (es) Proteinas f del vrs modificadas y metodos de uso de las mismas.
WO2010146598A3 (en) Stable, dried rotavirus vaccine, compositions and process for preparation thereof
CA2817005A1 (en) Rabies glycoprotein virus-like particles (vlps)
JP2017533218A5 (zh)
WO2007048086A3 (en) Canine influenza virus and related compositions and methods of use
PL2443202T3 (pl) Wodna zawiesina aktywowanego powierzchniowo węglanu wapnia, otrzymane produkty i ich zastosowania
PE20100035A1 (es) Proteina de cereal hidrolizado parcialmente
NZ600891A (en) Process for the preparation of pharmaceutical compositions for the sustained release of somatostatin analogs
MY184277A (en) Formulations of deoxyccholic acid and salts thereof
AR079951A1 (es) Proceso para producir una bebida acida con contenido de proteina de soja sometida a tratamiento termico y un producto obtenido mediante dicho proceso
WO2012054907A3 (en) Novel hemagglutinin 5 (h5) proteins for the treatment and prevention of influenza infections
MX349837B (es) Composicion de transglutaminasa seca.
WO2011051916A3 (en) Stabilized protein formulations and use thereof
NZ613554A (en) Caprylate viral deactivation
UA110933C2 (uk) Композиція для лікування есенціальної тромбоцитемії
TH108771A (th) สารปรุงสำเร็จที่แห้งแบบเยือกแข็งที่มีวัคซีนไข้หวัดใหญ่ และวิธีสำหรับผลิตสารดังกล่าว
MX2015009141A (es) Formulaciones de albu-bche, preparacion y usos de las mismas.
TH108771B (th) สารปรุงสำเร็จที่แห้งแบบเยือกแข็งที่มีวัคซีนไข้หวัดใหญ่ และวิธีสำหรับผลิตสารดังกล่าว
WO2010095978A3 (ru) Способ получения препарата проинсулина для перорального применения
MY157490A (en) Method for purifying aqueous compositions
NZ704819A (en) Dry powder vancomycin compositions and associated methods

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170307